Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - April 13.07.2026 FAPR.LN IE000WX2HZQ7 250,002.00 USD 6,426,356.32 25.705  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100® Moderate Buffer UCITS ETF - March 13.07.2026 QMAR.LN IE0006S0EBF2 50,002.00 USD 1,239,334.78 24.786  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Artificial Intelligence UCITS ETF 13.07.2026 FTAI IE000YIQZ0H6 225,002.00 USD 6,651,029.32 29.560  ...
-

BioTalent Canada and Fairleigh Dickinson University Vancouver Partner to Strengthen Life Sciences Talent Development

OTTAWA, Ontario & VANCOUVER, British Columbia--(BUSINESS WIRE)--BioTalent Canada and Fairleigh Dickinson University (FDU) Vancouver have announced a new partnership designed to advance workforce development, deepen industry engagement and support growth in British Columbia’s life sciences sector. The partnership brings together BioTalent Canada’s expertise in bioscience workforce development, labour market intelligence, skills development and employer engagement with FDU Vancouver’s growing foc...
-

Del Monte Corporation to Report Second Quarter 2026 Financial Results

CORAL GABLES, Fla.--(BUSINESS WIRE)--Del Monte Corporation to Report Second Quarter 2026 Financial Results...
-

Ouster Announces Date for Second Quarter 2026 Earnings Call

SAN FRANCISCO--(BUSINESS WIRE)--Ouster, Inc. (Nasdaq: OUST) (“Ouster” or the “Company”), a leader in sensing and perception for Physical AI, today announced that it will report its financial results for the quarter ended June 30, 2026 after the market closes on Thursday, August 6, 2026 and host a conference call that day at 5:00 p.m. ET to discuss its results. Registration for the webcast can be completed by visiting the following website prior to, or on the day of, the conference call: https:/...
-

Personalis Accelerates Global Expansion with UKCA Marking for NeXT Personal®, Expanding MRD Access and Biopharma Support in Great Britain

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that it has achieved UKCA (United Kingdom Conformity Assessed) marking for its NeXT Personal Dx test. This critical regulatory milestone enables the clinical use of Personalis’ ultrasensitive Minimal Residual Disease (MRD) detection technology across Great Britain, encompassing England, Wales, and Scotland.The UKCA marking confirms that the NeXT Personal Dx tes...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF- June 13.07.2026 MJUN LN IE000CO3P697 150,002.00 USD 3,805,197.02 25.368  ...
-

Lickly Names Nita Patel Chief Marketing Officer as Creator Marketing Moves Into Performance Era

LOS ANGELES--(BUSINESS WIRE)--Lickly, an audience-first creator intelligence platform built for data-driven brands ready to scale repeatable marketing campaigns, today announced the appointment of Nita Patel as Chief Marketing Officer.As Lickly prepares for its broader public launch in early fall, Patel will lead brand strategy, product marketing, demand generation and go-to-market execution while using the platform to build Lickly itself. The approach will put Lickly’s intelligence model to wor...
-

AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the fourth quarter and fiscal year 2026, which ended May 31, 2026. Fiscal Year 2026 Fourth Quarter Financial Highlights     Quarter Ended May 31, 2026   Pro Forma* YoY Growth Pro Forma* N...